320 related articles for article (PubMed ID: 3157441)
21. Purification of stable protein kinase C from mouse brain cytosol by specific ligand elution using fast protein liquid chromatography.
Jeng AY; Sharkey NA; Blumberg PM
Cancer Res; 1986 Apr; 46(4 Pt 2):1966-71. PubMed ID: 3456269
[TBL] [Abstract][Full Text] [Related]
22. Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells.
Greenebaum E; Nicolaides M; Eisinger M; Vogel RH; Weinstein IB
J Natl Cancer Inst; 1983 Mar; 70(3):435-41. PubMed ID: 6300498
[TBL] [Abstract][Full Text] [Related]
23. Prevention of phorbol ester receptor down modulation in human myeloblastic leukemia ML-1 cells by differentiation-stimulating serum components.
Sakagami H; Hromchak R; Block A
Cancer Res; 1984 Aug; 44(8):3330-5. PubMed ID: 6331642
[TBL] [Abstract][Full Text] [Related]
24. Activation of protein kinase C and specific phosphorylation of a Mr 90,000 membrane protein of promotable BALB/3T3 and C3H/10T1/2 cells by tumor promoters.
Chida K; Hashiba H; Sasaki K; Kuroki T
Cancer Res; 1986 Mar; 46(3):1055-62. PubMed ID: 3080229
[TBL] [Abstract][Full Text] [Related]
25. Phorbol ester binding to chemotactically responding and nonresponding Walker 256 carcinosarcoma cells.
Clarke PR; Varani J
Cancer Res; 1984 Nov; 44(11):4967-71. PubMed ID: 6593115
[TBL] [Abstract][Full Text] [Related]
26. Fatty acid modification of C3H 10T 1/2 fibroblast cells: changes in benzo(a)pyrene metabolism and phorbol ester binding.
Matsui MS; Jeffrey AM
Cancer Res; 1987 May; 47(9):2385-92. PubMed ID: 3471326
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cell communication between Balb/c 3T3 cells by tumor promoters and protection by cAMP.
Enomoto T; Martel N; Kanno Y; Yamasaki H
J Cell Physiol; 1984 Nov; 121(2):323-33. PubMed ID: 6092391
[TBL] [Abstract][Full Text] [Related]
28. Characterization of phorbol ester receptors and their down-modulation in GH4C1 rat pituitary cells.
Jaken S; Tashjian AH; Blumberg PM
Cancer Res; 1981 Jun; 41(6):2175-81. PubMed ID: 6786733
[TBL] [Abstract][Full Text] [Related]
29. Presence of specific binding sites for phorbol ester tumor promoters in human epidermal and dermal cells in culture but lack of down regulation in epidermal cells.
Chida K; Kuroki T
Cancer Res; 1983 Aug; 43(8):3638-42. PubMed ID: 6574816
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters.
Kikkawa U; Takai Y; Tanaka Y; Miyake R; Nishizuka Y
J Biol Chem; 1983 Oct; 258(19):11442-5. PubMed ID: 6311812
[TBL] [Abstract][Full Text] [Related]
31. Changes in protein kinase C and cAMP-dependent kinase in lymphocytes after treatment with 12-O-tetradecanoylphorbol-13-acetate or concanavalin A: quantitation of activities with an in situ gel assay.
Grove DS; Mastro AM
J Cell Physiol; 1987 Sep; 132(3):415-27. PubMed ID: 2821014
[TBL] [Abstract][Full Text] [Related]
32. The role of hydrophobic interactions in the phospholipid-dependent activation of protein kinase C.
Snoek GT; Feijen A; Hage WJ; van Rotterdam W; de Laat SW
Biochem J; 1988 Oct; 255(2):629-37. PubMed ID: 3202836
[TBL] [Abstract][Full Text] [Related]
33. Tumor promoter binding to rat mammary cell cultures: role of receptors in the inhibition of dome formation.
Sonnenberg A; Dulbecco R; Okada S
Cancer Res; 1983 Mar; 43(3):1059-65. PubMed ID: 6297718
[TBL] [Abstract][Full Text] [Related]
34. Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from Sencar mice.
Solanki V; Slaga TJ
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2549-53. PubMed ID: 6941309
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of lymphocyte protein kinase C by unsaturated fatty acids.
May CL; Southworth AJ; Calder PC
Biochem Biophys Res Commun; 1993 Sep; 195(2):823-8. PubMed ID: 8396928
[TBL] [Abstract][Full Text] [Related]
36. Relationship between mezerein-mediated biological responses and phorbol ester receptor occupancy.
Jaken S; Shupnik MA; Blumberg PM; Tashjian AH
Cancer Res; 1983 Jan; 43(1):11-4. PubMed ID: 6600158
[TBL] [Abstract][Full Text] [Related]
37. Phorbol esters mediate phospholipid-free activation of rat brain protein kinase C.
Da Silva C; Fan XT; Martelly I; Castagna M
Cancer Res; 1990 Apr; 50(7):2081-7. PubMed ID: 2107968
[TBL] [Abstract][Full Text] [Related]
38. Antagonist of phorbol ester receptor-mediated chemotaxis in mouse peritoneal macrophages.
Sturm RJ; Smith BM; Lane RW; Laskin DL; Harris LS; Carchman RA
Cancer Res; 1983 Oct; 43(10):4552-6. PubMed ID: 6309370
[TBL] [Abstract][Full Text] [Related]
39. Differential activation and inhibition of lymphocyte proliferation by phorbol esters, mezerein, teleocidin, and okadaic acid.
Grove DS; Mastro AM
Cancer Res; 1991 Jan; 51(1):82-8. PubMed ID: 1988110
[TBL] [Abstract][Full Text] [Related]
40. [The actions of TPA-type as well as non-TPA type tumor promoters and their mechanism(s) in tumor promotion].
Fujiki H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):758-65. PubMed ID: 2870684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
